These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 17954719)

  • 1. The burden of blood pressure-related disease: a neglected priority for global health.
    Perkovic V; Huxley R; Wu Y; Prabhakaran D; MacMahon S
    Hypertension; 2007 Dec; 50(6):991-7. PubMed ID: 17954719
    [No Abstract]   [Full Text] [Related]  

  • 2. The Socioeconomic Effects of Uncontrolled Hypertension.
    Athanasakis K
    Curr Vasc Pharmacol; 2017; 16(1):5-9. PubMed ID: 28412912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The burden of blood pressure: where are we and where should we go?
    Hamet P
    Can J Cardiol; 2000 Dec; 16(12):1483-7. PubMed ID: 11137913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The treatment of hypertension in Canada: are we making progress?
    McAlister FA
    CMAJ; 1999 Sep; 161(6):713-4. PubMed ID: 10513278
    [No Abstract]   [Full Text] [Related]  

  • 5. Excess morbidity and cost of failure to achieve targets for blood pressure control in Europe.
    Hansson L; Lloyd A; Anderson P; Kopp Z
    Blood Press; 2002; 11(1):35-45. PubMed ID: 11926349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The basic treatment of arterial hypertension (II). Pharmacological treatment].
    Pascual J; Orte L; Ortuño J
    Med Clin (Barc); 1994 Nov; 103(18):699-707. PubMed ID: 7808078
    [No Abstract]   [Full Text] [Related]  

  • 7. Differences in medical expenditure according to drug prices.
    Ueshima H
    Hypertens Res; 2006 May; 29(5):301-2. PubMed ID: 16832148
    [No Abstract]   [Full Text] [Related]  

  • 8. The value of risk assessment and burden of disease analyses.
    Lawes CM; Vander Hoorn S; Rodgers A
    J Hypertens; 2006 Apr; 24(4):783-4. PubMed ID: 16531809
    [No Abstract]   [Full Text] [Related]  

  • 9. Comparison of health costs associated with treatment of hypertension with a calcium channel blocker and angiotensin-converting enzyme inhibitor in the United States and Japan.
    Sakamaki Y; Sasamura H; Ikeda S; Ikegami N; Saruta T
    Hypertens Res; 2006 May; 29(5):333-8. PubMed ID: 16832153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges for the management of hypertension in low-resource settings.
    Mendis S
    Ethn Dis; 2003; 13(2 Suppl 2):S67-70. PubMed ID: 13677416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular disease costs associated with uncontrolled hypertension.
    Flack JM; Casciano R; Casciano J; Doyle J; Arikian S; Tang S; Arocho R
    Manag Care Interface; 2002 Nov; 15(11):28-36. PubMed ID: 12449899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension: prevalence and economic implications.
    Dalzell MD
    Manag Care; 2003 Aug; 12(8 Suppl Hypertension):6-11. PubMed ID: 12971587
    [No Abstract]   [Full Text] [Related]  

  • 13. The burden and correlates of hypertension in rural Ghana: a cross-sectional study.
    Williams EA; Keenan KE; Ansong D; Simpson LM; Boakye I; Boaheng JM; Awuah D; Nkyi CA; Nyannor I; Arhin B; Alder S; Benson LS; Dickerson TT
    Diabetes Metab Syndr; 2013; 7(3):123-8. PubMed ID: 23953175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic factors in formulating a national policy on the prevention by drugs of cardiovascular disease.
    Malcolm L
    N Z Med J; 1990 Aug; 103(896):402-4. PubMed ID: 2117264
    [No Abstract]   [Full Text] [Related]  

  • 15. High blood pressure in the elderly.
    Bots ML; Grobbee DE; Hofman A
    Epidemiol Rev; 1991; 13():294-314. PubMed ID: 1765115
    [No Abstract]   [Full Text] [Related]  

  • 16. High systolic blood pressure increases the risk of obtaining a disability pension because of cardiovascular disease: a cohort study of 903 174 Swedish men.
    Kark M; Rasmussen F
    Eur J Cardiovasc Prev Rehabil; 2009 Oct; 16(5):597-602. PubMed ID: 19738474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Global cardiometabolic risk profile in patients with hypertension: results from the Turkish arm of the pan-European GOOD survey.
    Kabakcı G; Aydın M; Demir I; Kırma C; Özerkan F
    Turk Kardiyol Dern Ars; 2010 Jul; 38(5):313-20. PubMed ID: 21200100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. World Hypertension Day 2007.
    Jones DW; Hall JE
    Hypertension; 2007 May; 49(5):939-40. PubMed ID: 17420339
    [No Abstract]   [Full Text] [Related]  

  • 19. Saving 100 million lives by improving global treatment of hypertension and reducing cardiovascular disease risk factors.
    Frieden TR; Jaffe MG
    J Clin Hypertens (Greenwich); 2018 Feb; 20(2):208-211. PubMed ID: 29370471
    [No Abstract]   [Full Text] [Related]  

  • 20. High blood pressure in Latin America: a call to action.
    Rubinstein A; Alcocer L; Chagas A
    Ther Adv Cardiovasc Dis; 2009 Aug; 3(4):259-85. PubMed ID: 19561117
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.